By Albert Manfredi
Albert “Albi” Manfredi is a sophomore in the School of Engineering and Applied Science at the University of Pennsylvania. He majors chemical and biomolecular engineering, concentrating in pharmaceuticals and biotechnology, and hopes to complete the joint legal studies and history minor between The Wharton School and the College of Arts and Sciences.
With 15% of the United States population now fully vaccinated against COVID-19, the government-subsidized vaccine rollout is starting to be viewed as a massive success for public health and the pharmaceutical industry . Not only have vaccines distributed at a rapid pace, but they have managed to stay affordably priced as the government purchases and distributes them to ensure they are accessible to those in need. However, paying for quick relief while overlooking long-term regulation may come with a cost. Two weeks ago, Pfizer, Moderna, and Johnson & Johnson executives promised investors increased prices for current vaccines and future booster shots during the “non-pandemic” phase . This profit-scheme comes in spite of the fact that the majority of vaccine funding, approximately $30 billion, came from taxpayers and the federal government . These actions call into question the ethics of the pharmaceutical industry and whether it requires government intervention to prioritize public health before investor profits.
By Albert Manfredi
Albert “Albi” Manfredi is a sophomore in the School of Engineering and Applied Science at the University of Pennsylvania. He intends to major in chemical and biomolecular engineering and hopes to complete the joint legal studies and history minor between The Wharton School and the College of Arts and Sciences.
In the midst of a tumultuous year, the Department of Justice (DOJ) has recently filed historic antitrust lawsuits against large technology companies like Google and Visa. For some, this course of action is long overdue as the lax enforcement of antitrust allowed big information technology companies like Google, Facebook, Amazon, and Apple, to control the internet, extract huge fees from manufacturers, and dominate markets to limit competition and consolidate economic power . For corporate America, these new suits have the potential to create a precedent for future cases, bringing a more regulated approach to the industry.